orphan drugs market
Pharmaceutical Companies Increasingly Adopting Orphans
August 09 by Pharma IQOrphan diseases had been traditionally neglected. By their definition, they were often rare and so it was not financial sound to pursue developing a treatment for them. In 1983 however, the US gover...
Orphan Drugs – Reinventing Economies of Scale
November 16 by Cristina FalcãoEconomies of scale come in many flavors. Including the oddity flavor where the number of manufactured products decreases and the size of markets shrink. Orphan drugs are economies of scale’...
Renewed Realisation of Orphan Drug Market Potential
December 08 by Pharma IQOrphan drugs were previously considered not worthwhile for development by pharmaceutical companies due to their small patient base, which was translated by some to mean small revenues. Orphan buz...
